Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide

The aggregation of β-amyloid peptide (Aβ) is one potential cause for Alzheimer’s disease (AD). Heparin can either promote or inhibit Aβ aggregation. The sulfation pattern and chain size determine its binding affinity and its role. Using 2D-NMR analysis and molecular modelling, the binding motif of h...

Full description

Bibliographic Details
Main Authors: Xiang Zhou, Yuanyuan Wang, Wei Zheng, Guangxiu Deng, Fuyi Wang, Lan Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.824146/full
_version_ 1819326777891225600
author Xiang Zhou
Yuanyuan Wang
Wei Zheng
Guangxiu Deng
Fuyi Wang
Lan Jin
author_facet Xiang Zhou
Yuanyuan Wang
Wei Zheng
Guangxiu Deng
Fuyi Wang
Lan Jin
author_sort Xiang Zhou
collection DOAJ
description The aggregation of β-amyloid peptide (Aβ) is one potential cause for Alzheimer’s disease (AD). Heparin can either promote or inhibit Aβ aggregation. The sulfation pattern and chain size determine its binding affinity and its role. Using 2D-NMR analysis and molecular modelling, the binding motif of heparin oligoaccharides to Aβ was determined to be HexA-GlcNS-IdoA2S-GlcNS6S. Iduronic acid epimerization and 6-O-sulfation are key factors for the binding affinity, while 3-O-sulfation of Arixtra (heparin pentasaccharide) is not involved in the binding to Aβ. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) was used to study the glycosaminoglycan (GAG)-peptide complex and identified V12HHQKL17 as the binding site of GAG at Aβ. Furthermore, an MTT assay was applied to evaluate the anti-Aβ fibril formation function of heparin tetrasaccharide, and indicated that the heparin tetrasaccharide with the defined sequence represents a promising inhibitor of Aβ aggregation.
first_indexed 2024-12-24T13:00:21Z
format Article
id doaj.art-c275268b50854043abf908ab78284b1d
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-12-24T13:00:21Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-c275268b50854043abf908ab78284b1d2022-12-21T16:54:10ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-02-01910.3389/fmolb.2022.824146824146Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta PeptideXiang Zhou0Yuanyuan Wang1Wei Zheng2Guangxiu Deng3Fuyi Wang4Lan Jin5National Glycoengineering Research Center, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao, ChinaBeijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, ChinaBeijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems Institute of Chemistry, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Beijing, ChinaNational Glycoengineering Research Center, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaNational Glycoengineering Research Center, Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology, Shandong University, Qingdao, ChinaThe aggregation of β-amyloid peptide (Aβ) is one potential cause for Alzheimer’s disease (AD). Heparin can either promote or inhibit Aβ aggregation. The sulfation pattern and chain size determine its binding affinity and its role. Using 2D-NMR analysis and molecular modelling, the binding motif of heparin oligoaccharides to Aβ was determined to be HexA-GlcNS-IdoA2S-GlcNS6S. Iduronic acid epimerization and 6-O-sulfation are key factors for the binding affinity, while 3-O-sulfation of Arixtra (heparin pentasaccharide) is not involved in the binding to Aβ. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) was used to study the glycosaminoglycan (GAG)-peptide complex and identified V12HHQKL17 as the binding site of GAG at Aβ. Furthermore, an MTT assay was applied to evaluate the anti-Aβ fibril formation function of heparin tetrasaccharide, and indicated that the heparin tetrasaccharide with the defined sequence represents a promising inhibitor of Aβ aggregation.https://www.frontiersin.org/articles/10.3389/fmolb.2022.824146/fullheparinβ-amyloid peptideinteractionNMRhydrogen/deuterium exchange mass spectrometry
spellingShingle Xiang Zhou
Yuanyuan Wang
Wei Zheng
Guangxiu Deng
Fuyi Wang
Lan Jin
Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
Frontiers in Molecular Biosciences
heparin
β-amyloid peptide
interaction
NMR
hydrogen/deuterium exchange mass spectrometry
title Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
title_full Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
title_fullStr Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
title_full_unstemmed Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
title_short Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide
title_sort characterizing heparin tetrasaccharides binding to amyloid beta peptide
topic heparin
β-amyloid peptide
interaction
NMR
hydrogen/deuterium exchange mass spectrometry
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.824146/full
work_keys_str_mv AT xiangzhou characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide
AT yuanyuanwang characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide
AT weizheng characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide
AT guangxiudeng characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide
AT fuyiwang characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide
AT lanjin characterizingheparintetrasaccharidesbindingtoamyloidbetapeptide